showed that either induction of the endogenous DNAJB1-PRKACA fusion gene by CRISPR/Cas9 or overexpression of the fusion gene cDNAs was sufficient to induce FLC-like tumors in young adult mice. This evidence concerns the gene DNAJB1 and fibrolamellar hepatocellular carcinoma.